京泉華(002885.SZ):聘任鞠萬金為總經理及財務負責人
格隆匯3月23日丨京泉華(002885.SZ)公佈,公司於2022年3月23日召開了第四屆董事會第一次會議,會議審議通過了《關於聘任總經理的議案》《關於聘任副總經理的議案》《關於聘任財務負責人的議案》《關於聘任董事會祕書的議案》《關於聘任證券事務代表的議案》《關於聘任內審負責人的議案》,全體董事一致同意聘任鞠萬金為公司總經理;同意聘任汪兆華為公司常務副總經理;同意聘任李戰功、辛廣斌為公司副總經理;同意聘任鞠萬金為公司財務負責人;同意聘任辛廣斌為公司董事會祕書;同意聘任曹文智、馮謙為公司證券事務代表;同意聘任劉仲昆為公司內審負責人,上述人員任期自董事會決議之日起至第四屆董事會任期屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.